SCHEMBL29256111

SCHEMBL29256111

CCOC(=O)c1cc2n(n1)CCN(Cc1ccc(OC)cc1)C2=O.CCOC(=O)c1cc2n(n1)CCNC2=O

nearest known ligand 0.70

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
CYP1A2 P05177 2/20 0.70
CYP2C19 P33261 2/20 0.70
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
PKM P14618 1/20 0.57
CYP2C9 P11712 1/20 0.47
LMNA P02545 5/20 0.45
TP53 P04637 3/20 0.45
POLB P06746 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9941742 0.92 ALDH1A1 (0.82) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MEN1
SCHEMBL29256112 0.88 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MEN1
SCHEMBL2520510 0.82 CDC7 (0.46) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MEN1
SCHEMBL2526216 0.81 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MEN1
SCHEMBL4494006 0.80 ALDH1A1 (0.82) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MEN1
SCHEMBL18183854 0.79 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MEN1
SCHEMBL2521926 0.77 SMN1; SMN2 (0.80) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MEN1
SCHEMBL24687925 0.74 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MEN1
SCHEMBL19902330 0.73 CDC7 (0.44) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MEN1
SCHEMBL9938533 0.73 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118027039-A Crystal of substituted piperazine derivative and preparation method thereof 成都百裕制药股份有限公司 2024-05-14 CN disclosed